{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:28:02Z","timestamp":1782818882102,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies suggest that circulating endothelial progenitor cells (EPCs) may influence the response to cardiac resynchronization therapy (CRT). The aim of this study was to evaluate the effect of CRT on EPC levels and to assess the impact of EPCs on long-term clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Population and methods<\/jats:title>\n                    <jats:p>\n                      Prospective study of 50 patients submitted to CRT. Two populations of circulating EPCs were quantified previously to CRT implantation: CD34\n                      <jats:sup>+<\/jats:sup>\n                      KDR\n                      <jats:sup>+<\/jats:sup>\n                      and CD133\n                      <jats:sup>+<\/jats:sup>\n                      KDR\n                      <jats:sup>+<\/jats:sup>\n                      cells. EPC levels were reassessed 6\u2009months after CRT. Endpoints during the long-term follow-up were all-cause mortality, heart transplantation, and hospitalization for heart failure (HF) management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The proportion of non-responders to CRT was 42% and tended to be higher in patients with an ischemic vs non-ischemic etiology (64% vs 35%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.098). Patients with ischemic cardiomyopathy (ICM) showed significantly lower CD34\n                      <jats:sup>+<\/jats:sup>\n                      KDR\n                      <jats:sup>+<\/jats:sup>\n                      EPC levels when compared to non-ischemic dilated cardiomyopathy patients (DCM) (0.0010\u2009\u00b1\u20090.0007 vs 0.0030\u2009\u00b1\u20090.0024 cells\/100 leukocytes,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.032). There were no significant differences in baseline EPC levels between survivors and non-survivors nor between patients who were rehospitalized for HF management during follow-up or not. At 6-month follow-up, circulating EPC levels were significantly higher than baseline levels (0.0024\u2009\u00b1\u20090.0023 vs 0.0047\u2009\u00b1\u20090.0041 CD34\n                      <jats:sup>+<\/jats:sup>\n                      KDR\n                      <jats:sup>+<\/jats:sup>\n                      cells\/100 leukocytes,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.010 and 0.0007\u2009\u00b1\u20090.0004 vs 0.0016 vs 0.0013 CD133\n                      <jats:sup>+<\/jats:sup>\n                      \/KDR\n                      <jats:sup>+<\/jats:sup>\n                      cells\/100 leukocytes,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with ICM showed significantly lower levels of circulating EPCs when compared to their counterparts. CRT seems to improve the pool of endogenously circulating EPCs and reduced baseline EPC levels seem not to influence long-term outcomes after CRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01713-8","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T06:02:33Z","timestamp":1590300153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Improvement in circulating endothelial progenitor cells pool after cardiac resynchronization therapy: increasing the list of benefits"],"prefix":"10.1186","volume":"11","author":[{"given":"Gon\u00e7alo","family":"Crist\u00f3v\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Crist\u00f3v\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Elvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lino","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fontes","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3103-4353","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Ant\u00f3nio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"1","key":"1713_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/eurheartj\/ehi001","volume":"26","author":"D Fischer","year":"2005","unstructured":"Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J. 2005;26(1):65\u20139.","journal-title":"Eur Heart J"},{"issue":"3","key":"1713_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2006.07.191","volume":"119","author":"M Nonaka-Sarukawa","year":"2007","unstructured":"Nonaka-Sarukawa M, Yamamoto K, Aoki H, Nishimura Y, Tomizawa H, Ichida M, et al. Circulating endothelial progenitor cells in congestive heart failure. Int J Cardiol. 2007;119(3):344\u20138.","journal-title":"Int J Cardiol"},{"issue":"7","key":"1713_CR3","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/01.ATV.0000073832.49290.B5","volume":"23","author":"M Hristov","year":"2003","unstructured":"Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003;23(7):1185\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1713_CR4","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1161\/STROKEAHA.107.499236","volume":"39","author":"K Chu","year":"2008","unstructured":"Chu K, Jung KH, Lee ST, Park HK, Sinn DI, Kim JM, et al. Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke. 2008;39(5):1441\u20137.","journal-title":"Stroke"},{"issue":"22","key":"1713_CR5","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","volume":"111","author":"C Schmidt-Lucke","year":"2005","unstructured":"Schmidt-Lucke C, R\u00f6ssig L, Fichtlscherer S, Vasa M, Britten M, K\u00e4mper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111(22):2981\u20137.","journal-title":"Circulation"},{"issue":"10","key":"1713_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa043814","volume":"353","author":"N Werner","year":"2005","unstructured":"Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353(10):999\u20131007.","journal-title":"N Engl J Med"},{"issue":"24","key":"1713_CR7","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","volume":"346","author":"W Abraham","year":"2002","unstructured":"Abraham W, Fisher W, Smith A, Delurgio D, Leon A, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845\u201353.","journal-title":"N Engl J Med"},{"issue":"12","key":"1713_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.amjcard.2005.02.009","volume":"95","author":"E D\u00edaz-Infante","year":"2005","unstructured":"D\u00edaz-Infante E, Mont L, Leal J, Garc\u00eda-Bolao I, Fern\u00e1ndez-Lozano I, Hern\u00e1ndez-Madrid A, et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol. 2005;95(12):1436\u201340.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1713_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/pace.12334","volume":"37","author":"N Antonio","year":"2014","unstructured":"Antonio N, Soares A, Carvalheiro T, Fernandes R, Paiva A, Ventura M, et al. Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle? Pacing Clin Electrophysiol. 2014;37(6):731\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"18","key":"1713_CR10","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","volume":"25","author":"GS Bleumink","year":"2004","unstructured":"Bleumink GS, Knetsch AM, Sturkenboom MCJM, Straus SMJM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - the Rotterdam study. Eur Heart J. 2004;25(18):1614\u20139.","journal-title":"Eur Heart J"},{"issue":"46","key":"1713_CR11","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","volume":"34","author":"JG Cleland","year":"2013","unstructured":"Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34(46):3547\u201356.","journal-title":"Eur Heart J"},{"issue":"3","key":"1713_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ahj.2008.11.006","volume":"157","author":"JGF Cleland","year":"2009","unstructured":"Cleland JGF, Calvert MJ, Verboven Y, Freemantle N. Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study. Am Heart J. 2009;157(3):457\u201366.","journal-title":"Am Heart J"},{"issue":"6","key":"1713_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/europace\/eus390","volume":"15","author":"J Boidol","year":"2013","unstructured":"Boidol J, \u015aredniawa B, Kowalski O, Szulik M, Mazurek M, Sokal A, et al. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial. Europace. 2013;15(6):835\u201344.","journal-title":"Europace"},{"key":"1713_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"4","key":"1713_CR15","first-page":"1","volume":"9","author":"Y Chen","year":"2014","unstructured":"Chen Y, Duan C, Liu F, Shen S, Chen P, Bin J. Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis. PLoS One. 2014;9(4):1\u201310.","journal-title":"PLoS One"},{"issue":"4","key":"1713_CR16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1161\/01.CIR.84.4.1589","volume":"84","author":"SH Kubo","year":"1991","unstructured":"Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84(4):1589\u201396.","journal-title":"Circulation"},{"issue":"4","key":"1713_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1582-4934.2004.tb00474.x","volume":"8","author":"M Hristov","year":"2004","unstructured":"Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8(4):498\u2013508.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1713_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/01.CIR.0000136813.89036.21","volume":"110","author":"M Valgimigli","year":"2004","unstructured":"Valgimigli M, Rigolin GM, Fucili A, Della Porta M, Soukhomovskaia O, Malagutti P, et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110(10):1209\u201312.","journal-title":"Circulation"},{"issue":"10","key":"1713_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/eurheartj\/ehm011","volume":"28","author":"HD Theiss","year":"2007","unstructured":"Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, et al. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J. 2007;28(10):1258\u201364.","journal-title":"Eur Heart J"},{"issue":"13","key":"1713_CR20","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","volume":"109","author":"C Heeschen","year":"2004","unstructured":"Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109(13):1615\u201322.","journal-title":"Circulation"},{"issue":"9","key":"1713_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/hrt.2006.102657","volume":"93","author":"Y Michowitz","year":"2007","unstructured":"Michowitz Y, Goldstein E, Wexler D, Sheps D, Keren G, George J. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart. 2007;93(9):1046\u201350.","journal-title":"Heart"},{"issue":"2","key":"1713_CR22","first-page":"309","volume":"116","author":"L Koller","year":"2016","unstructured":"Koller L, Hohensinner P, Sulzgruber P, Blum S, Maurer G, Wojta J, et al. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure. Thromb Haemost. 2016;116(2):309\u201316.","journal-title":"Thromb Haemost"},{"issue":"8","key":"1713_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004106","volume":"10","author":"A Samman Tahhan","year":"2017","unstructured":"Samman Tahhan A, Hammadah M, Sandesara P, Hayek S, Kalogeropoulos A, Alkhoder A, et al. Progenitor cells and clinical outcomes in patients with heart failure. Circ Heart Fail. 2017;10(8):e004106.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"1713_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.cjca.2013.06.010","volume":"29","author":"AC Alba","year":"2013","unstructured":"Alba AC, Lalonde SD, Rao V, Walter SD, Guyatt GH, Ross HJ. Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study. Can J Cardiol. 2013;29(12):1657\u201364.","journal-title":"Can J Cardiol"},{"issue":"1","key":"1713_CR25","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/hh1301.093953","volume":"89","author":"M Vasa","year":"2001","unstructured":"Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1\u20137.","journal-title":"Circ Res"},{"issue":"3","key":"1713_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1540-8159.2006.00331.x","volume":"29","author":"GN Theodorakis","year":"2006","unstructured":"Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A, et al. Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol. 2006;29(3):255\u201361.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"1713_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clinbiochem.2012.11.002","volume":"46","author":"AE Stanciu","year":"2013","unstructured":"Stanciu AE, Vatasescu RG, Stanciu MM, Iorgulescu C, Vasile AI, Dorobantu M. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects. Clin Biochem. 2013;46(3):230\u20134.","journal-title":"Clin Biochem"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01713-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01713-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01713-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T19:30:00Z","timestamp":1621798200000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01713-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1713"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01713-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16519\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16519\/v2","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study patients signed an informed consent, and the study was approved by the ethics committee of Centro Hospitalar e Universit\u00e1rio de Coimbra and is in accordance with the criteria of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}